Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on June 13, 2025
God Is Good All Ways and Always: A Memoir of Faith, Healing, and Hope
EIN Presswire
·
June 13, 2025
In God is Good All Ways and Always, Donna Watson shares how faith turned pain into healing—offering hope and strength for those facing life’s hardest seasons. TRENTON, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- In her heart-moving debut …
CareGivers of America Announces New Location
EIN Presswire
·
June 13, 2025
CareGivers of America opens a new Margate location, boosting access to high-quality home care services for families across Broward County. MARGATE, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- CareGivers of America, a recognized and trusted …
THE FLORIDA ASSOCIATION OF HEALTHY START COALITIONS LAUNCHES NEW BRANDING AND WEBSITE
EIN Presswire
·
June 13, 2025
TALLAHASSEE, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- The Florida Association of Healthy Start Coalitions (FAHSC) is excited to announce their rebranding with a new logo and website. Harnessing the power of over 30 years as a leading …
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
GlobeNewswire
·
June 13, 2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 13, 2025
LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and …
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 13, 2025
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in …
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies
GlobeNewswire
·
June 13, 2025
RIYADH, Saudi Arabia, June 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
Worker Protection from Heat Stress: Now More Than Ever, It's Up to Employers to Do The Right Thing
GlobeNewswire
·
June 13, 2025
St. Paul, MN, June 13, 2025 (GLOBE NEWSWIRE) -- With federal cost-cutting and deregulation reshaping workplace safety oversight, the responsibility to protect workers from extreme heat is falling squarely on employers. While OSHA’s National Emphasis …
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
GlobeNewswire
·
June 13, 2025
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its presence in the U.S. market. A Pre-IND application was submitted to …
The Dental Medical Convergence Announces Featured Article and Podcast Interview on KevinMD Highlighting Dangers of Dental Infections
GlobeNewswire
·
June 13, 2025
Eustis, Florida , June 13, 2025 (GLOBE NEWSWIRE) -- The Dental Medical Convergence, a nonprofit dedicated to educating the public about the link between oral health and systemic disease, announced today that KevinMD—widely recognized as social media’s …
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
GlobeNewswire
·
June 13, 2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
GlobeNewswire
·
June 13, 2025
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd. (“131” or the “Company”) and Launchit Solutions Inc. (“Launchit”) are pleased to announce that the Company, Launchit and 1001240330 Ontario Inc. (“Subco”), a wholly-owned …
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
GlobeNewswire
·
June 13, 2025
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device …
GT Biopharma Appoints New Member to its Board of Directors
GlobeNewswire
·
June 13, 2025
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer …
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
GlobeNewswire
·
June 13, 2025
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma – – Data supports ongoing Phase 2 …
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
GlobeNewswire
·
June 13, 2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for …
Sienna Announces June Dividend
GlobeNewswire
·
June 13, 2025
MARKHAM, Ontario, June 13, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of June 2025, representing $0. …
Safety Shot, Inc. and Yerbaé Brands Corp Majority Shareholders Approve Proposed Acquisition of Yerbaé Brands Corp.
GlobeNewswire
·
June 13, 2025
SCOTTSDALE, AZ, June 13, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today announced that it a majority of its shareholders have voted by a majority to approve the …
Tiziana Life Sciences to Present at the Bio International Convention
GlobeNewswire
·
June 13, 2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 13, 2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …